『2 Minutes with Joey - AMGN Stock News』のカバーアート

2 Minutes with Joey - AMGN Stock News

2 Minutes with Joey - AMGN Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Amgen (AMGN) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • AMGN Today - Aug 13: Steady Day for Amgen

    AMGN Today - Aug 13: Steady Day for Amgen
    2026/08/13
    Hey there! It’s Joey here, your friendly long-time investor, breaking down the day’s action. Today we’re talking about Amgen, and guess what? It had a pretty chill day, barely moving up by 0.38%.

    So, what went down? Amgen’s stock price closed at around 417.75. Yeah, not a wild ride at all—just kind of floated along. Volume was steady, matching its average, which means folks weren’t rushing to buy or sell like crazy. It’s like everyone was just hanging out, not too worried.

    Now, why did it stay so steady? Well, there’s some chatter about Amgen’s recent performance. They posted strong Q2 results and even raised their guidance for 2026. That’s usually a good sign, right? But here’s the kicker: some analysts are saying it might be fully valued now. So, while the numbers look solid, there’s a bit of caution in the air. People are trying to figure out if it’s worth chasing after or if it’s already priced in. Also, Daiwa Securities just bumped their price target to $430 from $390, which is a bit of a boost, but again, it’s all about how investors feel about that valuation.

    Oh, and just a little nugget for you—Tema ETFs just increased their stake in Amgen. So, some folks are still feeling good about it, even if the stock’s taking a breather today.

    That’s the scoop! Amgen’s playing it cool, and while there’s some optimism with the earnings and guidance, there’s also that nagging feeling about whether it’s peaked. Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • AMGN Today - Aug 12: Small Move, Some Buzz

    AMGN Today - Aug 12: Small Move, Some Buzz
    2026/08/12
    Hey there! It’s Joey here, your friendly market buddy, and I’m breaking down the day for you. Today, we’re talking about Amgen, and it was a pretty chill day on the stock front—closed up just a smidge, like 0.2%. Not exactly a wild ride, but hey, a win's a win, right?

    So, what went down? Amgen started off the day with some solid trading, but honestly, it felt like a slow bleed for most of it. It didn’t really pop off, but it didn’t crash either. Just kind of hung around that $415 mark. You know those days where you’re just waiting for something to happen? Yeah, that was today.

    Now, let’s talk about why. There’s been some chatter in the air lately. Tema ETFs decided to up their stake in Amgen, which is usually a good sign. Plus, one of the directors, Charles Holley, got a stock award and reported his trust holdings. That kind of insider action can spark some interest. Also, G&S Capital jumped in with a fresh investment of about $1.58 million. So, there’s definitely some buzz around the stock, but it didn’t translate into a big move today.

    On the horizon, Amgen’s Q2 earnings call had some analysts asking some pretty interesting questions. Those calls can be a goldmine for info, so keep an ear out for that if you’re following the stock.

    Alright, that’s a wrap for today! Just remember, this is all for fun and to keep you in the loop—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • AMGN Today - Aug 11: Mixed Signals in the Market

    AMGN Today - Aug 11: Mixed Signals in the Market
    2026/08/11
    Hey there! It’s Joey here, your friendly investor buddy, breaking down the day’s action. Today, we’re talking about Amgen, and it was a bit of a red day. The stock dipped about three bucks, which is a small hit, right?

    So, what happened? Amgen slid down by 0.75%. It didn’t really catch a break today, even though it wasn’t a crazy drop. The trading volume was right on average, so it wasn’t like everyone was panicking or anything. Just a slow bleed, you know?

    Now, why did it happen? Well, there were a few things buzzing around. First off, there's chatter about Charles Schwab Trust upping their stake in Amgen. That usually sounds like good news, but it didn’t really light a fire under the stock. Then, there’s the news about Amgen’s director, Charles Holley, getting a stock award and reporting his holdings. Again, cool stuff for insiders, but it didn’t seem to move the needle for everyone else.

    On the flip side, Guggenheim raised Amgen’s price target to $388, which is a positive sign. But honestly, it feels like the market is just digesting all this info without any big reactions. So, nobody really knows why it got smoked today. Just one of those days, I guess.

    Looking ahead, Amgen’s Q2 earnings call had some solid analyst questions, so there’s definitely some interest in what they’re doing. That could be something to keep an eye on, especially if they drop any juicy details.

    Alright, that’s a wrap for today! Just remember, this is all for fun and info – not financial advice. Stay chill and invest smart! Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません